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Abstract
Background: Acceptability of mobile phone text messaging as a means of asynchronous communication between health care
systems and patients is growing. The US Department of Veterans Affairs (VA) has adopted an automated texting system (aTS)
for national rollout. The aTS allows providers to develop clinical texting protocols to promote patient self-management and allows
clinical teams to monitor patient progress between in-person visits. Texting-supported hepatitis C virus (HCV) treatment has not
been previously tested.
Objective: Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), we developed an aTS HCV
protocol and conducted a mixed methods, hybrid type 2 effectiveness implementation study comparing two programs supporting
implementation of the aTS HCV protocol for medication adherence in patients with HCV.
Methods: Seven VA HCV specialty clinics were randomized to usual aTS implementation versus an augmented implementation
facilitation program. Implementation process measures included facilitation metrics, usability, and usefulness. Implementation
outcomes included provider and patient use of the aTS HCV protocol, and effectiveness outcomes included medication adherence,
health perceptions and behaviors, and sustained virologic response (SVR).
Results: Across the seven randomized clinics, there were 293 facilitation events using a core set of nine implementation strategies
(157 events in augmented implementation facilitation, 136 events in usual implementation). Providers found the aTS appropriate
with high potential for scale-up but not without difficulties in startup, patient selection and recruitment, and clinic workflow
integration. Patients largely found the aTS easy to use and helpful; however, low perceived need for self-management support
contributed to high declination. Reach and use was modest with 197 patients approached, 71 (36%) enrolled, 50 (25%) authenticated,
and 32 (16%) using the aTS. In augmented implementation facilitation clinics, more patients actively used the aTS HCV protocol
compared with usual clinic patients (20% vs 12%). Patients who texted reported lower distress about failing HCV treatment
(13/15, 87%, vs 8/15, 53%; P=.05) and better adherence to HCV medication (11/15, 73%, reporting excellent adherence vs 6/15,
40%; P=.06), although SVR did not differ by group.
Conclusions: The aTS is a promising intervention for improving patient self-management; however, augmented approaches to
implementation may be needed to support clinician buy-in and patient engagement. Considering the behavioral, social,
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organizational, and technical scale-up challenges that we documented, successful and sustained implementation of the aTS may
require implementation strategies that operate at the clinic, provider, and patient levels.
Trial Registration: Retrospectively registered at ClinicalTrials.gov NCT03898349;
https://clinicaltrials.gov/ct2/show/NCT03898349
(J Med Internet Res 2019;21(8):e14750)  doi: 10.2196/14750
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Introduction
Short message service (SMS or texting) is becoming an accepted
means of asynchronous communication between health care
systems and patients, supporting appointment attendance,
medication taking, and medication refill reminders [1]. Texting
interventions have been studied across a range of clinical
domains and stages of care [2]. Despite the ubiquity of cell
phones and the established benefits of texting interventions,
there has been limited research on the implementation of patient
texting in health care systems [2]. Although texting interventions
have yielded improvements in processes of care and health
outcomes, results have been achieved through heterogenous
approaches, revealing significant implementation knowledge
gaps [3-5]. Furthermore, technologies intended to directly
engage patients (patient-facing technologies) encounter distinct
implementation challenges when clinical staff are needed to
promote patients’ adoption of the technology.
Implementation facilitation, a kind of meta-strategy composed
of multiple implementation strategies, uses experts in clinical,
process, and implementation issues to solve problems and offer
support that enables others to institute and sustain practice
change [6-8]. Although facilitation is versatile, it has not been
extensively studied as part of health information technology
implementation or sustainability efforts [9,10].
In 2016, the US Department of Veterans Affairs (VA) began
piloting an automated text messaging system (aTS) for patient
self-management modeled after texting systems used in the UK
National Health Service (NHS), Australia, and Canada [11,12].
The aTS, titled Annie after Annie Fox, RN, the first nurse to be
awarded a Purple Heart, provides patients with a technology to
become more engaged in their own care through
condition-specific protocols to accentuate the key points of care
plans. The aTS can send one-way messages and interpret patient
messages following specified syntax and then reply through
rule-based logic with two-way (bidirectional) messages.
The rollout of VA’s aTS presented a unique opportunity to
examine implementation in the context of a large, integrated
health care system. We chose to evaluate the implementation
and effectiveness of the aTS across specialty care hepatitis C
virus (HCV) clinics and test the utility of implementation
facilitation. We focused exclusively on HCV treatment because
it involves a time-limited predefined course of daily medication,
and high adherence is required to achieve sustained virologic
response (SVR) and avoid drug resistance [13,14]. Adherence
to follow-up appointments and regular bloodwork are also
essential to successful treatment.
While there is ample evidence regarding the effectiveness of
texting to support medication taking in other disease contexts,
no studies, to our knowledge, have examined HCV treatment
support via texting [2]. Given the evidence for similar
conditions, we hypothesized that texting for HCV would have
comparable effects. As such, we conducted a hybrid type 2
implementation study to simultaneously examine both clinical
and implementation outcomes and thus generate evidence in
this area [15]. Our aims were to (1) qualitatively and
quantitatively assess implementation outcomes for the aTS and




This was a multisite, mixed methods, randomized, two-group
hybrid type 2 study design comparing the effectiveness of usual
implementation (UI) and augmented implementation (AI)
facilitation. Matched comparison (ie, no intervention) sites
helped to determine effectiveness of the aTS in aiding HCV
treatment. The study was reviewed by the institutional review
board at the Edith Nourse Rogers Memorial Veterans Hospital
in Bedford, Massachusetts, and determined to be a quality
improvement study and therefore exempt (VA Handbook
1058.05) [16]. The project was conducted from February 2017
through February 2018. Due to an error, this study was
registered retrospectively. The study was registered at
ClinicalTrials.gov (NCT03898349).
Setting and Participants
Nine HCV clinics participated in this study. Seven served as
intervention sites and two as matched comparisons. The group
of clinics selected reflects a purposive sample based on criteria
including clinic size and complexity as well as geography. HCV
clinics were recruited via a national HCV provider email listserv
and monthly HCV provider phone call. The seven HCV
intervention clinics selected were randomly assigned to either
UI or AI, using set randomization, which, with small sample
sizes, helps to achieve balance on a set of relevant
characteristics—in this case, urban/suburban setting and HCV
patient volume [17]. Two additional comparison clinics were
selected purposively because they had similar patient volume,
clinic complexity, and geographic locale to the other
participating clinics [18]. In total, data were collected from nine
VA clinics: four AI clinics, three UI clinics, and two comparison
clinics. Care teams within the HCV clinics had different
compositions and involved pharmacists, nurse practitioners,
registered nurses, and social worker to varying degrees.
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Text Messaging Protocol for Hepatitis C Virus
Treatment
At the time of implementation, usual care for HCV included
starting a patient on daily oral medication for 8 to 16 weeks
with follow-up in-person visits, blood lab work, and medication
refills at 2- or 4-week intervals. Using the aTS in the context
of HCV was intended to improve processes, outcomes of care,
and satisfaction with care. The HCV texting protocol included
reminder text messages for each modifiable behavior in the
HCV treatment process: medication taking, appointment
attendance, laboratory completion, and self-efficacy to
encourage continued engagement in treatment. Typically, clinic
providers and staff would reach out by phone or letter to remind
patients of HCV appointments, labs, and refills. To ensure
alignment with standard treatment processes and local clinic
workflow, each of the seven clinics co-designed and tailored
the HCV texting protocol (eg, adjusting messaging logic from
2 to 4 weeks for different treatment intervals) in conjunction
with study team members (VY, KM, and national aTS program
office technical and clinical specialists). Motivational messages
were written to be supportive in nature, promote
self-management, and increase feelings of connection to the
treatment team. Principles of universal design were also
incorporated to ensure that different ranges of abilities, access,
and equity were considered and the widest reach and benefit of
the HCV texting protocol could be achieved [19]. Sample HCV
texting protocol messages are as follows:
• Medication reminder: “Hi, it’s Annie, with a helpful
reminder. Did you remember to take your HepC medication
today?”
• Appointment reminder: “Hi, Annie here. Don’t forget about
your upcoming HepC appointment. If you do not know
when your appointment is, please call to find out.”
• Lab reminder: “Annie & VA Liver team here. You are due
to have a blood draw this week so we can see how your
HepC meds are working. Please call your VA care team if
you need help getting your labs.”
• Motivational message: “Don’t forget that the HepC Team
is here to support you in your HepC treatment efforts. Call
your care team if we can help you. – Annie”
Messages could be tailored for content (eg, adding clinic name,
phone number, or appointment date) and timing (eg, adjusting
time of day that medication reminder is sent) through patient
and provider discussion at the time of aTS enrollment or later
to reflect patient preferences. Veterans who did not use the aTS
received otherwise standard HCV care.
Usual Implementation and Augmented Implementation
Facilitation
Facilitation was employed to support adoption of the aTS at
participating clinics, with facilitation delivered by a primary
(VY) and a secondary (KM) external facilitator. During the
4-month preimplementation phase, the functions of the external
facilitators included engaging local, regional, and national
stakeholders to garner support for the aTS. The implementation
phase took place over 6 months and differed between UI and
AI. The postimplementation (evaluation) phase took place over
3 months.
Usual Implementation Clinics
UI clinics received the start-up experience that VA designed
for all new clinics instituting the aTS. This involved a live
virtual demonstration of the aTS and access to an aTS resource
website that included promotional materials and training guides.
UI clinics could receive troubleshooting assistance from the
external facilitators by phone or email but only if and when they
reached out to the them.
Augmented Implementation Clinics
In addition to the start-up experience for UI sites, AI clinics
received an implementation toolkit, support for local champion
development, and proactive outreach by the primary external
facilitator. The toolkit was developed by our team based on a
formative evaluation that involved visits to five VA medical
centers around the country that were using a pilot version of
the aTS for conditions other than HCV. The toolkit contained
sections on evidence of texting in health care, suggestions for
gaining leadership and clinic support for technology like the
aTS, use of champions to support aTS adoption, tips and tools
on how to use the aTS, and aTS promotional materials to
encourage clinic and patient participation. Each AI clinic
received one in-person visit from the primary external facilitator
early in their implementation efforts. Additionally, the primary
external facilitator initiated check-ins with AI clinic champions
throughout implementation.
Facilitation was delivered via email, phone, and in person. In
the preimplementation period, to establish rapport and trust,
there was more emphasis on phone calls and in-person meetings,
whereas during implementation, those modes were used less
while use of emails increased. Facilitation calls lasted from 5
minutes to 90 minutes (40-minute average) and site visits by
the external facilitator lasted 2 to 4 hours. The facilitation
meta-strategies included assessing for readiness to implement,
site visits, identifying and preparing champions, developing
and distributing educational materials, building a coalition, local
technical assistance, and tailoring implementation to context
[20,21].
Conceptual Framework
Our evaluation was guided by the Practical, Robust
Implementation and Sustainability Model (PRISM), which
defines a set of factors for consideration when designing,
implementing, sustaining, and evaluating interventions [22].
PRISM posits that the extent to which an intervention achieves
results can be linked to the four PRISM domains: intervention
characteristics (via patient and organizational perspectives),
intervention recipients (via patient and organizational
perspectives), external environment, and implementation and
sustainability infrastructure.
Measures and Data Collection
PRISM domains (intervention characteristics, recipients via
patient and organizational perspectives, external environment,
and implementation and sustainability infrastructure) guided
the measures and data collection and are denoted in
parentheticals.
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Implementation Processes: Facilitation (Implementation
and Sustainability Infrastructure)
The primary external facilitator logged facilitation events on a
tracking sheet, including facilitation date, length of time, mode
of delivery (ie, email, phone call, or in-person visit), purpose,
notes, and other observations. If multiple facilitation events
occurred in one day, only one event per person per day was
counted.
Implementation Outcomes: Texting Use (Intervention)
Providers logged the number of patients who were offered the
aTS and noted whether patients enrolled or declined, including
the reason for declining. The content of patient text message
replies was extracted from the aTS portal. To be eligible for the
texting protocol, patients had to be starting HCV medication
treatment during the implementation period. There were four
steps to initiate a patient on the aTS: (1) providers verbally
offered patients the aTS, (2) providers registered interested
patients in the aTS portal and assigned them the HCV protocol,
(3) once a patient was registered, the aTS would send an
automated text message requesting the patient authenticate
themselves by replying to this initial text message thus
prompting the assigned HCV protocol to begin, and (4) patients
actively texted with the aTS.
Clinical Effectiveness Outcomes
Medication adherence was measured via patient text response
rate, operationalized as the number of days of text-confirmed
medication taking divided by the number of days receiving
medication reminder texts. Consistent with other adherence
standards, an affirmative text response rate of ≥80% was
considered high adherence [23]. Clinical data, including HCV
treatment regimen and duration and lab results, were extracted
from VA’s national HCV dashboard based on data from VA
corporate data warehouse. The goal of HCV treatment is to
achieve cure or SVR, meaning there is an undetectable HCV
lab result 12 weeks after completion of treatment.
Questionnaires (Recipients, Intervention,
Implementation)
Patients at each clinic completed baseline and follow-up (after
8 to 12 weeks of using the aTS) questionnaires. The comparison
clinics followed the same schedule, although without any use
of texting. Patient questionnaires covered the topics of self-rated
health status, adherence, illness perception, health engagement
and activation, technology use, experiences with the aTS
(usability, usefulness, working alliance), and demographics
[24-29]. Provider questionnaires followed the same schedule
and covered topics of technology experience, quality
improvement culture, climate and readiness for implementation,
satisfaction with current local HCV care processes, experiences
with the aTS (usability and usefulness), and demographics
[30-33]. Questionnaires were pretested for clarity, redundancy,
and relevancy by two patients and two providers and two
implementation scientists independent of the study team.
Semistructured Interviews (All Practical, Robust
Implementation and Sustainability Model Domains)
Qualitative semistructured telephone interviews were conducted
with patients and providers who used or were invited to use the
aTS. Interviews were conducted in the follow-up period during
September and October 2017. The interview guides were
informed by PRISM domains and explored issues regarding
barriers and facilitators to aTS uptake and use (intervention,
implementation, and sustainability), usability and usefulness of
the aTS (intervention), and how the aTS was experienced by
patients and providers (recipients) in the course of treatment
and daily practice (external environment). Interviews were
conducted by members of the study team not involved in
facilitation (BP, CG) and lasted about 30 minutes.
Due to the small number of participants who successfully used
the aTS, it was decided that comparing texters, regardless of
group (AI or UI), against nontexters was necessary. For
effectiveness outcomes measures, we combined patients who
were using the aTS regardless of whether they were in UI or AI
clinics. These were referred to as texters. In contrast, nontexters
were defined as patients who agreed to participate in the project
but never completed the step of authenticating themselves with
the aTS (at either UI or AI clinics), and thus never received any
text messages, as well as patients from the two comparison
clinics that did not implement the aTS (Figure 1). For each
questionnaire or qualitative interview completed, patients
received a $10 store gift card to compensate them for their time.
Figure 1. Flow diagram of clinics in the study and participants, identified as texters and nontexters.
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Descriptive and bivariate analyses of facilitation log data were
conducted to compare facilitation dose between UI and AI
groups. Descriptive and bivariate analyses were conducted on
provider and patient questionnaires, text message frequencies,
and clinical data to assess differences between implementation
groups (UI and AI) in implementation outcomes. We then
compared clinical effectiveness outcomes between texters and
nontexters. We examined patient progression through the aTS
initiation process by calculating the percentage retained from
one step to the next by UI and AI group. Chi-square tests were
used to assess differences between the two groups. All analyses
were conducted in RStudio version 1.0.153 (The R Foundation),
and statistical significance was defined as P<.05.
Qualitative interviews were audio recorded, transcribed
verbatim, and analyzed using NVivo 11 (QSR International Pty
Ltd) software. Thematic analysis of all qualitative data
(interview transcripts, facilitator meeting notes, text messages)
was conducted [34]. PRISM domains provided deductive a
priori codes and other codes emerged through inductive coding.
The triangulation of quantitative and qualitative data served as
the final step of analysis.
Results
Findings are arranged by relevant PRISM domain (intervention
characteristics, recipients via both patient and organizational
perspectives, external environment, and implementation and
sustainability infrastructure).
Recipient Perspectives and Organizational
Characteristics
Of the nine HCV clinics, seven were in the northeastern United
States (including the two comparison clinics), and two were in
the western United States (one each AI and UI). In total, fifteen
providers across the intervention clinics (seven in UI and eight
in AI) were trained to use the aTS and completed a baseline
demographic questionnaire. Ten of these providers eventually
enrolled patients and completed a follow-up questionnaire (five
providers were unable to enroll any patients). At baseline, clinic
and provider characteristics were balanced on age, sex, and
technology experience (data not shown) across AI, UI, and
comparison clinics. Provider surveys indicated there were no
differences between clinics in the two implementation arms on
readiness to implement the aTS, including on measures of
perceived evidence strength for texting, organizational context,
and implementation climate (data not shown). These surveys
indicated there were, however, differences in satisfaction with
clinic HCV treatment practices: 100% (7/7) of UI compared
with 50% (4/8) of AI providers were satisfied with their local
HCV treatment processes (P=.04).
External Environment
Providers were generally eager to support HCV treatment with
the aTS because improving HCV treatment was a national and
local VA priority. One UI provider mentioned that their clinic
had already been considering creating a texting reminder system:
We’re actually really excited to use it [the aTS] with
our patients. This is something that we had talked
about doing or developing something like this to see
what the impact could be on improving adherence to
appointments, adherence to medications for patients.
Another provider lamented:
I wish this [the aTS] could have come earlier.
Implementation Facilitation Processes
Figure 2 summarizes email, phone, and in-person facilitation
events (n=293) across the seven intervention clinics. Facilitation
effort was relatively modest, initially, as new clinics were
adopting and learning the aTS, rising to the busiest period in
months 4 to 7 and tapering off in months 8 to 10. AI clinics had
an average of 39 facilitation events compared with 45 for UI
clinics (P=.17), or about weekly contact. Only 10% of providers
reported (via postimplementation survey) that they could have
implemented the aTS without facilitation. The association
between facilitation dose and provider-initiated aTS recruitment
was positive and linear, although not statistically significant
(r=.71, P=.07).
Providers across implementation arms had largely positive
feedback about the facilitation received to support aTS
implementation. One provider explained the value of an
accessible facilitator:
...whenever you’re using new technology and new
approaches with the technology component, it’s just
good to have somebody that you can, who’s very
responsive...and can find out the answer for you in a
timely fashion.
In the case of AI clinics, providers highlighted the value of the
in-person site visit because “when [the facilitator] came it kind
of clinched it,” suggesting the one-on-one visit helped providers
make the decision to use the aTS and provided an important
opportunity to ask clarifying questions and cement more of the
technical and logistical aspects of implementation. AI clinic
providers had mixed impressions of the toolkit. Providers felt
it provided needed information and was easy to understand;
however, some felt it was too long and overly dense. Several
suggested that an abridged quick start guide would have been
more useful.
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Figure 2. Facilitation events over time by clinic and implementation arm.
Implementation Outcomes
Implementation outcomes, UI versus AI, are depicted in the
retention diagram in Figure 3, which shows the percentage of
patients approached to participate in the aTS who progressed
from one step to the next. Across the seven aTS intervention
clinics, a total of 625 patients started HCV treatment during the
implementation period. Providers comparably offered the aTS
to 33% (92/278) of patients at UI sites and 30% (105/347) of
patients at AI sites who were starting HCV treatment (P=.45).
Notably, UI sites did better in the registration and authentication
steps, and AI sites did better in reaching the final step of aTS
message interaction. By implementation group there was a
significant difference in patient registration (42/278, 15%, UI
vs 29/347, 8%, AI; P=.01) and a borderline significant difference
in patient authentication (26/278, 9%, UI vs 24/347, 7%, AI;
P=.06). However, compared to UI site patients, a greater
percentage of AI site patients who authenticated their phone
numbers went on to actively respond to HCV messages (11/278,
4%, UI vs 21/347, 6%, AI; P<.001). Of 35 patients (14 UI vs
21 AI) receiving medication reminder text messages, 91%
(32/35) replied to at least one medication reminder. The mean
medication reminder response rate was 78% (SD 26%; median
89%), with no difference between groups (77% UI vs 79% AI;
P=.87).
Qualitative interviews with providers indicated that they were
often choosing to offer the aTS to younger and clinically less
complex candidate patients who they perceived to be more
technologically savvy and thus more likely to agree to use the
system. In correlation analysis, the number of patients to whom
the aTS was offered was inversely associated with providers’
baseline satisfaction with HCV care process (r=–0.65, P=.06)
and their length of time working in the VA health care system
(r=–0.78, P=.01). Nevertheless, all providers were surprised
that a high percentage of patients declined the aTS offer:
I thought a lot of people are going to be able to
participate, but I guess when we started offering them
[the text messages] some patients don’t, I guess
they’re not used to it, so they, most of the patients
that I offer to decline to participate.
Patient reasons for declining the aTS fell into four categories:
general disinterest (48%), texting apprehension, including cost
concerns (30%), beliefs of already being good at medication
adherence (12%), or beliefs that texting would duplicate other
self-management approaches (10%).
J Med Internet Res 2019 | vol. 21 | iss. 8 | e14750 | p. 6https://www.jmir.org/2019/8/e14750/
(page number not for citation purposes)
Yakovchenko et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 3. Texting engagement by implementation and facilitation arm. HCV: hepatitis C virus; aTS: automated texting system.
Patient Characteristics
There were few demographic differences between texters and
nontexters (Table 1), although texters were more likely to be
black (13/15, 87%, vs 6/15, 40%; P=.02) and less likely to have
a self-reported mental health or substance use disorder (9/15,
60%, vs 14/15, 93%; P=.03).
Clinical Effectiveness Outcomes
On the follow-up survey (Table 2), more texters versus
nontexters reported excellent health (4/15, 27%, vs 0/15, 0%;
P=.01) and greater ability to prevent or reduce problems
associated with their health (9/15, 60%, vs 2/15, 13%; P=.03).
A greater proportion of texters compared with nontexters had
overall less negative HCV illness perception and reported fewer
concerns about failing HCV treatment (13/15, 87%, vs 8/15,
53%, respectively; P=.05). Texters reported better or about
equal HCV treatment adherence than nontexters, including
having higher perceptions of their own HCV adherence than
did nontexters (11/15, 73%, reporting excellent adherence vs
6/15, 40%; P=.06). For patients for whom lab results were
available, 96% (27/28) of texters had achieved SVR compared
with 94% (153/163) of nontexters (P>.99), reflecting the high
cure rates possible with current HCV treatments and our small
sample size.
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Table 1. Patient characteristics by automated test messaging system use at follow-up (n=30).
P valueTextersb (n=15)Nontextersa (n=15)Characteristic
.5662 (5)62 (11)Age in years, mean (SD)
>.9914 (94)14 (94)Gender (male), n (%)
Race, n (%)
—13 (87)6 (40)African American or black
—2 (13)8 (53)White
—0 (0)1 (7)Other
>.990 (0)1 (7)Hispanic/Latino, n (%)
.93Marital status, n (%)
—4 (27)5 (33)Single/never married
—2 (13)2 (13)Married/in a relationship
—7 (47)7 (47)Divorced/separated
—2 (13)1 (7)Widowed
.383 (20)2 (13)Employment, currently working, n (%)
.25Income, n (%)
—2 (13)5 (33)>$10,000
—4 (27)5 (33)$10,000 to $20,000
—4 (27)4 (27)$20,000 to $40,000
—5 (33)1 (7)<$40,000
.27Education, n (%)
—5 (33)9 (60)High school or less
—10 (67)6 (40)Some college or more
.10Housing, n (%)
—11 (73)7 (47)Own apartment or house
—1 (7)6 (40)Hospital, domiciliary, shelter, street, drug treatment center
—3 (20)2 (13)With friend or relative




—Texting history, n (%)
.8311 (73)10 (67)Unlimited texting plan
.2712 (80)8 (53)Daily texting
aNontexters: patients who never received any text messages (could be from usual or augmented implementation clinics or comparison clinics).
bTexters: patients who used the automated texting system regardless of whether they were in usual or augmented implementation clinics.
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Table 2. Patient self-reported outcomes by texting group.
P valueTextersb (n=15)Nontextersa (n=15)Characteristics
Health status
.014 (27)0 (0)In general, how would you rate your health (excellent)?, n (%)
For how many days during the past 30 days..., n
.08510was your physical health not good?
.23813was your mental health not good?
.25510did poor physical or mental health keep you from doing your usual activities?
Patient activation (strongly agree), n (%)
.6112 (80)10 (67)I am responsible for taking care of my health.
.039 (60)2 (13)I am able to prevent or reduce problems associated with my health.
.1110 (67)5 (33)I can follow through on recommended medical treatment.
Illness perception (strongly disagree), n (%)
.327 (47)4 (27)Feeling angry, scared and/or depressed when I think about living with HCVc.
.588 (53)5 (33)Feeling that HCV controls my life.
.219 (60)5 (33)Feeling overwhelmed by the demands of living with HCV.
.5110 (67)7 (47)Not feeling motivated to go through HCV treatment.
.0513 (87)8 (53)Feeling that I am failing with my HCV treatment.
HCV treatment behavior (strongly disagree), n (%)
>.9912 (80)11 (73)I forget to take my HCV medicine(s).
.2614 (93)11 (73)I decide not to take my HCV medicine(s).
.5211 (73)12 (80)I forget to get my HCV prescription(s) filled.
.0713 (87)7 (47)I tend to forget to get my HCV lab and blood work done.
>.9912 (80)11 (73)I run out of my HCV medicine(s).
.1011 (73)5 (33)I tend to miss my doctors’ appointments, n (%)
Self-report HCV medication adherence
.2099 (2)95 (13)Percentage of HCV medication taken correctly in last 4 weeks, mean (SD)
.0611 (73)6 (40)Ability to take HCV medication as prescribed (excellent), n (%)
aNontexters: patients who never received any text messages (could be from usual or augmented implementation clinics or comparison clinics).
bTexters: patients who used the automated texting system regardless of whether they were in usual or augmented implementation clinics.
cHCV: hepatitis C virus.
Intervention Usability, Workflow, and Value
Usefulness and usability of the aTS was assessed with patients
and providers. Among those patients using the aTS (texters),
15 completed a follow-up survey and 13 also participated in a
semistructured interview. Another 15 patients who did not use
the aTS (nontexters) completed a follow-up survey. Among
patients, there were no differences by implementation arm (AI
vs UI) on patient measures of usability, usefulness, and degree
of working alliance with the aTS (data not shown). Texters
reported mostly positive sentiments about interacting with the
aTS, saying it was easy, simple, and “not rocket science.” Still,
some patients struggled with the aTS authentication syntax
(“Start”) due to capitalization and punctuation errors (eg,
“START” and “start.”). Most (12/15, 80%) preferred text
reminders to appointment reminders delivered by mail or phone.
About half (8/15, 53%) reported the cost of text messaging
could be a barrier to use, although at least 73% (11/15) had an
unlimited texting plan. In patients’ opinions, the aTS had
benefits in helping stay engaged in care, stay connected to their
health care team, and assisting with HCV medication adherence
(all 100% positive endorsements). As one patient recognized:
“I wouldn’t have been as efficient or effective without some
assistance” and it “[gave] me encouragement for doing what I
was supposed to.” Most patients (13/15, 87%) were on multiple
medications and viewed the aTS as supporting their overall
medication-taking routine: “I use [the aTS] for other medications
as well...I just group them all in together.” Providers
corroborated patient feedback by observing that the aTS “helps
relieve a lot of [patient] anxiety about missing a med.”
Provider perspectives on usefulness and usability were captured
via follow-up questionnaires and semistructured interviews.
Most providers (7/10, 70%) logged into the aTS at least weekly
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to either assign a protocol to a patient or monitor messages in
the aTS dashboard. Some providers tailored protocols according
to patient preferences, while other providers opted to retain
default protocol settings to streamline the enrollment process.
Some indicated that the message history data could be made
more usable.
Even with training and ongoing support, providers had startup
difficulties with the aTS:
I mean it took me a little while to familiarize myself
because the training versus actually doing it yourself,
you know, there’s a learning curve...
Half of providers (5/10, 50%) felt that enrolling patients was
difficult, and half also felt the aTS did not easily integrate into
clinical workflow. One third (3/10, 30%) said using the aTS
added a lot of work to their workday. Providers described the
aTS as a little bulky, a little cumbersome, and labor intensive.
To enhance uptake of the aTS, providers recommended the
system become more streamlined and more intuitive, particularly
at the stage of registering patients. Providers also suggested
integrating the aTS with other VA technologies, including
registration kiosks, the electronic medical record, and patient
portal (MyHealtheVet).
Although providers saw the aTS as a potential benefit to their
practice, sometimes they could not accommodate the additional
time to educate and enroll patients. A provider commented that
they “underappreciated the coaching that the patients require at
the time of enrolling.” There was a tendency for providers to
view the enrollment process as not in their scope of work and
as a task more suited for nurses or support staff, suggesting that
there be, “someone [nonprovider] assigned to assist with Annie.”
Notwithstanding difficulties incorporating the aTS into
established clinical practices, providers believed the aTS was
welcomed by patients (7/10, 70%), could enable clinics to meet
patient-centered care goals (9/10, 90%), and could lead to cost
savings for the VA (6/10, 60%). Most providers intended to
continue using the aTS for HCV (9/10, 90%) and would use it
for other health conditions after study completion (8/10, 80%).
Discussion
Principal Findings
To our knowledge, this is this first randomized evaluation of
implementation facilitation strategies intended to increase
adoption of VA’s aTS. We found that patients and providers
largely accepted and deemed the aTS appropriate, easy to use,
and useful, albeit with substantial barriers to uptake and
sustained use. Greater patient recruitment by providers was
associated with more facilitation and lower baseline satisfaction
with clinic HCV care processes. We found differences in
implementation outcomes. For some of the stages of aTS
implementation, patient engagement was higher in AI (vs UI).
Overall, 1 out of 6 patients (16%) who were offered the aTS
received aTS text messages. Texters, compared with nontexters,
felt more connected to their care team, confident in their HCV
medication taking, and more activated for self-management.
There were no differences, however, in clinical effectiveness
outcomes between patients based on use of the aTS system
(texters vs nontexters). Our results suggest that the aTS may
not be easy to implement but has better chances of success if
several PRISM domains are attended to at the adoption,
implementation, and sustainability phases.
Augmented Implementation Facilitation
Within the implementation and sustainability infrastructure
domain, a need for facilitated implementation was identified.
Considerable effort was needed to assist all clinics with aTS
adoption. Once implementation began, the aTS called for
episodic technical assistance rather than high-intensity, sustained
facilitation [35]. More facilitator-provider interaction appeared
to be related to higher aTS recruitment, as others have
demonstrated [36]. We also found that facilitation may have
replaced the need for a toolkit in this study because the facilitator
was highly accessible to providers. There is mounting evidence
that toolkits and manuals tend to be underused when other
implementation strategies are available [37,38]. This may be
due to toolkit development being unstandardized and thus highly
variable. For this reason, Hempel and colleagues [39] recently
provided recommendations for the content, development, and
evaluation of quality improvement toolkits. Of the
implementation facilitation meta-strategies in this study, it
appeared site visits had a strong influence on implementation,
suggesting that the interpersonal component of a
facilitator-provider dyad is paramount to successful
implementation.
Our results also indicate that despite differences in planned
facilitation approaches, there were no differences in the dose
of facilitation delivered, suggesting facilitation efficiency is
enhanced when it is delivered in person or is channeled through
a champion (as with augmented implementation sites) [40]. Our
findings are consistent with current literature that facilitator
effort tapers once clinics have commenced implementation
[37,41]. Facilitation, in many ways, is not formulaic and is
inherently dependent on local context and need. Notably, in our
work, a common implementation strategy was not
included—there was no explicit benchmarking or audit and
feedback component to the facilitation efforts. More guidelines
on how to gauge specific facilitation need (ie, activities, dose,
intensity, timing of start, and removal) are necessary, as are
ways to track, evaluate, and replicate with fidelity.
Assessing Readiness to Implement
Taking an organizational perspective to understand both the
intervention and its recipients illuminates several important
factors that can influence aTS uptake. Organizational readiness
between clinics differed in only one area: satisfaction with local
HCV care practices. Providers who were unsatisfied with their
HCV care practices may have perceived their clinics as needing
improvement and thus were more likely to embrace the aTS.
As such, some clinics were primed for the introduction of a new
practice, despite no mandate or clinical practice guideline
motivation. Once providers began implementing, however,
several believed the aTS did not integrate well into their
workflow and was a more fitting task for nonclinicians. Insights
from organizational readiness assessments tend to be underused
but may help understand facilitation mechanisms of action,
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which likewise remain poorly understood and often unmeasured
[42].
We also found variation in the assumptions made by providers
regarding patient candidacy for aTS recruitment. UI clinics
registered and enrolled more patients; however, AI clinic
patients authenticated their phone numbers at higher rates thus
triggering the text messages to start. Providers at AI clinics may
have been targeting patients more selectively, thus making their
recruitment more efficient. While potentially successful at their
AI clinics, in general, providers should be wary of the validity
of their selection heuristics, which studies indicate are often
unreliable [43]. It may be more appropriate to offer the aTS
universally to patients rather than selectively recruiting those
deemed more apt to agree, thereby reducing proficient user bias.
Future studies could explore alternative methods for introducing
the aTS and consenting and registering patients, such as through
patient opt-out and self-enrollment approaches. Since study
completion, adjustments to the aTS registration procedure now
allow for support staff to register patients in the aTS portal on
behalf of a consenting clinician.
Patient Behavior Change
There were several facilitating patient perspective elements
within the intervention and recipients domains important to aTS
use and sustainability. There was near universal positive
feedback from patients about the ease of use and benefits of the
aTS, however there were notable drop-offs in engagement during
phone number authentication due to syntax errors and possible
changes in willingness to use. After interacting with the aTS,
texters compared with nontexters reported feeling more activated
for self-management and adherence to medication and improved
health status, but no significant differences in clinical outcomes
were detected. As the transtheoretical model posits and as the
aTS begins to show, attitudinal changes precede behavior change
and may produce meaningful behavior change [44]. Because
polypharmacy among veterans is common, additional work is
required to understand the types of patients most likely to benefit
from texting interventions [45-47]. There may be other important
patient moderating variables, such as age and rurality, that
determine whether individuals choose to adopt the aTS [48].
While communication preferences are shifting in favor of texting
and other virtual modalities, slower-than-anticipated uptake of
technology tools for health care is common [49]. Nonetheless,
texting differs from other health technologies in that it reaches
patients where they are, at any time, and can accept responses
whenever patients are ready to offer them. In depth qualitative
work is needed to understand barriers to implementation and
sustained use of the aTS and how to redesign the enrollment
and engagement process.
Strengths and Limitations
This was the first study of VA’s aTS. Strengths of this study
are that PRISM was used to guide the evaluation, it was a
randomized design, and we simultaneously studied
implementation and effectiveness outcomes using mixed
methods. We believe this study makes an important contribution
to advancing the implementation science of texting
interventions.
Our study has several potential limitations. First, our study was
conducted within the VA and for the treatment of HCV;
therefore, not all settings or health behaviors were represented,
which limits our generalizability. Second, we selected clinics
that expressed interest in using the aTS, raising the potential
for selection bias. Third, the sicker, more socially and
psychologically vulnerable patients may not have been invited
by providers to participate in the aTS because of concerns that
it could be confusing or costly for them. This selection bias may
explain some of the apparent beneficial findings for texters.
Also, feedback on the aTS may have been subject to social
desirability bias. We did not adjust for multiple comparisons
due to the explanatory nature of the study.
Conclusions
Increasingly, health care systems are using technology to meet
patient expectations for electronic transactions, information
exchange, and on-demand access to providers. This was the
first study to examine the implementation and effectiveness of
an automated text messaging system in the VA generally and
for HCV treatment specifically. Despite positive perceptions
of the aTS, patient enrollment was challenging; however,
augmented facilitation resulted in greater sustained engagement
of patients once they enrolled. Importantly, among patients who
used the aTS (the texters) there was an indication of improved
illness perception, health engagement, and patient activation.
Our results suggest that the aTS can serve as an adjunct tool to
usual HCV care, provided it is appropriately integrated into
clinical workflow. Our study has implications for health care
systems making efforts to engage patients beyond episodic
in-person visits through patient-facing technologies. Findings
suggest that a large pool of potential texting adopters have yet
to realize benefits from this technology. While novel
technologies such as the aTS have considerable potential, they
also present distinct behavioral, social, and technical challenges
for implementation and scale-up.
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